Navigation Links
Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
Date:8/13/2009

ny duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance p
'/>"/>

SOURCE Amgen Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
8. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
9. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
10. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... LONDON , July 14, 2014  VirtualScopics, ... (AIM: IXI) jointly announced today the formation of a ... Edward Ashton , Ph.D., chief scientific officer, VirtualScopics, ... members. "The formation of this joint Scientific ... commercial and operational alliance we signed with IXICO plc ...
(Date:7/13/2014)... -- Eli Lilly and Company (NYSE: LLY ... in genetically engineered mice examining combination therapy with ... and beta-secretase inhibitor BACE (LY2811376). Data results found ... clumps of amyloid-beta protein in the brain – ... Alzheimer,s disease (AD) – than use of one ...
(Date:7/11/2014)... , July 11, 2014 Patient ... marketing and, consequently, organizations are turning to an ... As part of this evolving approach ... to educate, communicate and engage patients throughout their ... to patient empowerment. By mapping the patient journey ...
Breaking Medicine Technology:VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 2VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 3VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 4VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 5VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 6VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 7VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 8VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 9New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2
... Calif., April 29, 2011 First Quarter ... by 321 institutions, up from 239 in Q4 2010 ... revenue Operational focus enables lower planned expense growth in ... by Astellas NGX-1998 Phase 2 clinical trial continues in ...
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... cancers and infectious diseases, announced today that the company will ... Securities Research Conference San Francisco, CA, May 9-11, 2011 ... Dr. J. Joseph Kim, Ph.D., President & CEO May ...
Cached Medicine Technology:NeurogesX Reports First Quarter 2011 Results 2NeurogesX Reports First Quarter 2011 Results 3NeurogesX Reports First Quarter 2011 Results 4NeurogesX Reports First Quarter 2011 Results 5NeurogesX Reports First Quarter 2011 Results 6NeurogesX Reports First Quarter 2011 Results 7NeurogesX Reports First Quarter 2011 Results 8Inovio Pharmaceuticals to Present at Investor Conferences 2Inovio Pharmaceuticals to Present at Investor Conferences 3Inovio Pharmaceuticals to Present at Investor Conferences 4
(Date:7/14/2014)... 14, 2014 Many people are unhappy ... plastic surgery to reduce a “double chin.” A ... the need to go under the knife. Jawflex is ... jaw muscles, therefore tightening the skin in that area ... Jawflex is used for facial exercise, double chin elimination ...
(Date:7/14/2014)... Many diet plans often recommend eating plenty ... School of Public Health at the University of Alabama ... effect on weight loss. Now experts are suggesting that the ... of portion control to trigger measurable weight loss. ... controlling how much is consumed, simply by using a specially-designed ...
(Date:7/14/2014)... Seattle, WA (PRWEB) July 14, 2014 ... start up company Passionate Playground announces its first product ... adult pleasure product storage system. , Inventor ... for passionate consumers to have a storage solution for ... in the multibillion dollar adult retail industry. , Semer ...
(Date:7/14/2014)... 14, 2014 EurekaMag.com has newly published ... is a contagious liver disease that ranges in ... to a serious, lifelong illness that attacks the liver. ... have chronic Hepatitis C virus infection of which approximately ... research category covers all studies on Hepatitis C ...
(Date:7/14/2014)... "Medical devices, tests, and treatments are critical ... is a star when it comes to innovations in ... working on amazing products and ideas that are our ... to Dale Kaye CEO of the Innovation Tri-Valley ... brilliant minds and businesses that are leading society into ...
Breaking Medicine News(10 mins):Health News:Jawflex | Double Chin Exercise for Double Chin Reduction 2Health News:Increase Vegetable Consumption Has Zero Effect on Weight Loss – Portion Control is Recommended by Experts 2Health News:Increase Vegetable Consumption Has Zero Effect on Weight Loss – Portion Control is Recommended by Experts 3Health News:Passionate Playground launches Joyboxx 2Health News:Passionate Playground launches Joyboxx 3Health News:EurekaMag.com Publishes 64,900 New Studies on Hepatitis C 2Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 2Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 3Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 4
... of its,mission to help consumers feel better and lead ... WNI ), introduces two new,products that help maintain health ... Nutrition is key to staying healthy, but sometimes the ... compounds into our bodies. Schiff(R),3-Day Cleanse is a simple ...
... To World-Class ... Knowledge-Based Economy, ... Business at,Carnegie Mellon University and its Donald H. Jones ... Pittsburgh: Building Bridges to a City,s New Future." The,symposium, ...
... Comprehensive Eating,Disorders Program at Lucile Packard Children,s Hospital ... 18 to 21. This allows the program to,now ... "I am delighted that the Eating Disorders ... group," said Naomi Brown, PhD, an eating,disorders treatment ...
... trials reported using independent safety monitoring committees that can ... reactions, according to a major review published in the ... University of Nottingham carried out a detailed analysis of ... to see what safety measures were in place to ...
... http://www.pharmacyfraudsettlement.com with filed documents, fraud, allegations, ... ... As front line professionals dispensing medications to,Medicaid beneficiaries pharmacists are particularly ... and report Medicaid fraud, which is noted in the site., ...
... Peake: VA Reaches Out to Vets, Families in ... veterans and,their families during major emergencies, especially natural ... to deploy mobile pharmacies,that will provide vital medicine ... will also open up the facilities to help ...
Cached Medicine News:Health News:Schiff(R) Introduces New Supplement Products for Intestinal Health and Beauty Maintenance 2Health News:Carnegie Mellon's Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25 2Health News:Carnegie Mellon's Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25 3Health News:Carnegie Mellon's Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25 4Health News:Carnegie Mellon's Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25 5Health News:Carnegie Mellon's Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25 6Health News:Eating Disorders Program at Lucile Packard Children's Hospital Expands to Include Young Adults 2Health News:Eating Disorders Program at Lucile Packard Children's Hospital Expands to Include Young Adults 3Health News:Only 2 percent of child drug trials have independent safety checks 2Health News:Only 2 percent of child drug trials have independent safety checks 3Health News:CVS, America's Largest Pharmacy Chain, Pays Nearly $37 Million to Settle Federal and State Generic Drug Switching Charges 2Health News:CVS, America's Largest Pharmacy Chain, Pays Nearly $37 Million to Settle Federal and State Generic Drug Switching Charges 3Health News:VA Putting Mobile Pharmacies on the Road 2
... Protection Device features the ability to use ... lesion and a pre-loaded nitinol filter with ... Offering a fully rapid exchange system, the ... the indicated applications:, Carotid Indication - ,The ...
Clot-based Assay for Anti-FXa and/or Anti-Iia Therapies...
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Medicine Products: